News

Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method

Nes-Ziona, Israel, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd., (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy…

2 years ago

New Survey Highlights Dire State of Nursing in 2024, Finds Optimism from Nurses Still in Profession

IntelyCare's nationwide survey of nurses and nursing assistants points to workload, safety, care quality, and other concernsQUINCY, Mass., Feb. 07,…

2 years ago

One month left to submit a claim under the First Nations Drinking Water Settlement

TORONTO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Eligible First Nations communities and individuals have until March 7, 2024, to submit…

2 years ago

Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts

Daxor's ezBVA Lab Service Plays a Significant Role in Driving Growth and Fostering Widespread Adoption Oak Ridge, TN, Feb. 07,…

2 years ago

Skye Bioscience to Present at Oppenheimer Investor Conference

San Diego, California--(Newsfile Corp. - February 7, 2024) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a clinical-stage biotechnology company focused…

2 years ago

Groundbreaking Digital Health Platform Set to Transform Healthcare in the UK

LONDON, UK / ACCESSWIRE / February 7, 2024 / An innovative digital health platform is transforming how medical professionals manage…

2 years ago

V&P Scientific Partners With Bioz to Provide Researchers With Validated Product Insights

PALO ALTO, CA / ACCESSWIRE / February 7, 2024 / Bioz, Inc., a leading AI software company based in Silicon…

2 years ago

Perimed AB Partners with Serendipity Partners to Accelerate Growth and Innovation

JÄRFÄLLA, SWEDEN / ACCESSWIRE / February 7, 2024 / Perimed AB Perimed AB, a leading medical device company in the…

2 years ago

Spago Nanomedical Year-end Report January-December, 2023

LUND, SWEDEN / ACCESSWIRE / February 7, 2024 / Spago Nanomedical (STO:SPAGO.ST) (FRA:7UX.F) First cancer patient dosed with Tumorad®OCTOBER -…

2 years ago